Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorUniversity of Lausanne Hospitals
About this trial
This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients with suspicious prostate lesions found on high-field MRI.
Eligibility criteria
Qualifiers
Healthy male volunteers aged 18 and above.
Agree to be contacted for incidental findings
Signed informed consent
Adult men (≥18 y.o) with 3T MRI reported as sub-diagnostic due to metallic implants
Disqualifiers
Individuals with a history of prostate cancer
MR Contraindications as listed in the MR Safety Screening form
Contraindications as per MD instructions
Any condition making the patient unsuitable for the study
Trial design
Treatments tested in this trial
- Siemens Magnetom Free.Max 0.55T (Siemens Healthineers, Erlangen, Germany).
Treatment groups
74 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov